-
公开(公告)号:EP3022200B1
公开(公告)日:2017-03-01
申请号:EP14759317.2
申请日:2014-07-17
发明人: BURROWS, Jeremy , WYVRATT, Matthew , VAIDYA, Akhil , KORTAGERE, Sandhya , FAN, Erkang , CHATTERJEE, Arnab Kumar , NAGLE, Advait Suresh , KATO, Tomoyo
IPC分类号: C07D403/12 , C07D231/40 , A61K31/415 , A61K31/4184 , A61P33/06
CPC分类号: C07D231/40 , A61K31/415 , A61K31/4184 , A61K45/06 , C07D403/12
-
公开(公告)号:EP3022200A1
公开(公告)日:2016-05-25
申请号:EP14759317.2
申请日:2014-07-17
发明人: BURROWS, Jeremy , WYVRATT, Matthew , VAIDYA, Akhil , KORTAGERE, Sandhya , FAN, Erkang , CHATTERJEE, Arnab Kumar , NAGLE, Advait Suresh , KATO, Tomoyo
IPC分类号: C07D403/12 , C07D231/40 , A61K31/415 , A61K31/4184 , A61P33/06
CPC分类号: C07D231/40 , A61K31/415 , A61K31/4184 , A61K45/06 , C07D403/12
摘要: The present invention is related to a use of pyrazole derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to pyrazole derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
摘要翻译: 本发明涉及吡唑衍生物在制备用于预防或治疗疟疾的药物中的用途。 具体地,本发明涉及可用于制备用于抑制疟疾寄生虫增殖的药物制剂的吡唑衍生物。
-
3.
公开(公告)号:EP2483274B1
公开(公告)日:2014-10-29
申请号:EP10821105.3
申请日:2010-09-28
申请人: Board of Regents, The University of Texas System , Monash University , MMV Medicines for Malaria Venture , University of Washington , Glaxosmithkline Investigacion y Desarrollo, S.L.
发明人: RATHOD, Pradipsinh, K. , FLOYD, David , BURROWS, Jeremy , MARWAHA, Alka , GUJJAR, Ramesh , COTERON-LOPEZ, Jose , PHILLIPS, Margaret , CHARMAN, Susan, A. , MATTHEWS, David
IPC分类号: C07D487/04 , A61K31/519 , A61P33/06
CPC分类号: C07D487/04
-
公开(公告)号:EP4132918A1
公开(公告)日:2023-02-15
申请号:EP21717085.1
申请日:2021-04-08
IPC分类号: C07D401/04 , C07D403/04 , A61P33/06 , A61K31/4725 , A61K31/506
-
公开(公告)号:EP3892332A1
公开(公告)日:2021-10-13
申请号:EP20169099.7
申请日:2020-04-09
IPC分类号: A61P33/06 , C07D401/04 , C07D403/04 , A61K31/4725 , A61K31/506
摘要: The present invention is related to new derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to dihydroisoquinoline derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
-
6.
公开(公告)号:EP2483274A2
公开(公告)日:2012-08-08
申请号:EP10821105.3
申请日:2010-09-28
申请人: Board of Regents, The University of Texas System , Monash University , Medicines For Malaria Venture , University of Washington , Glaxosmithkline Investigacion y Desarrollo, S.L.
发明人: RATHOD, Pradipsinh, K. , FLOYD, David , BURROWS, Jeremy , MARWAHA, Alka , GUJJAR, Ramesh , COTERON-LOPEZ, Jose , PHILLIPS, Margaret , CHARMAN, Susan, A. , MATTHEWS, David
IPC分类号: C07D487/04 , A61K31/519 , A61P33/06
CPC分类号: C07D487/04
摘要: Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula (IX): and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.
-
-
-
-
-